Interaction of angiotensin II and mechanical stretch on vascular endothelial growth factor production by human mesangial cells

Journal of the American Society of Nephrology

Volumn 10, Issue 4, 1999, Pages 730-737

  Gruden, Gabriella ^a   Thomas, Stephen ^a   Burt, Davina ^a   Zhou, Wudin ^b   Chusney, Gary ^a   Gnudi, Luigi ^a   Viberti, Giancarlo ^a,c  

^a Unit for Metabolic Medicine   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; LOSARTAN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HORMONAL REGULATION; HUMAN; HUMAN CELL; MECHANICAL STIMULATION; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS REGULATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM;

EID: 0032983409     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Pinto JR, Viberti GC: The patient with diabetes mellitus. In: Oxford Textbook of Clinical Nephrology, edited by Cameron S, Davison AM, Grunfeld J-P, Kerr D, Ritz E, Oxford, Oxford Medical University Press 1998, pp 504-524
2. Viberti GC, Moghensen CE, Groop LC, Pauls JF, for the European Microalbuminuria Captopril Study Group: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 217: 275-279, 1994
3. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462, 1993
4. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacologic amelioration of glomerular capillary pressure. J Clin Invest 77: 1925-1930, 1986
5. Mauer SM: Structural-functional correlation of diabetic nephropathy. Kidney Int 45: 612-622, 1994
6. Gruden G, Thomas S, Burt D, Lane S, Chusney G, Sacks S, Viberti GC: Mechanical stretch induces vascular permeability factor in human mesangial cells: Mechanisms of signal transduction. Proc Natl Acad Sci USA 94: 12112-12116, 1997
7. Collins PD, Connoly DT, Williams TJ: Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br J Pharmacol 109: 195-199, 1993
8. Brenchley PE: VEGF/VPF: A modulator of microvascular function with potential roles in glomerular pathophysiology. J Nephrol 9: 10-17, 1996
9. Iijima K, Yoshikawa N, Connoly D, Nakamura H: Expression of vascular permeability factor by mesangial cells [Abstract]. J Am Soc Nephrol 3: 514a, 1992
10. Dzau VJ, Ingelfinger JR: Molecular biology and pathophysiology of the intrarenal renin-angiotensin system. J Hypertens 7[Suppl 7]: S3-S8, 1989
11. Anderson S, Jung FF, Ingelfinger JR: Renal renin-angiotensin system in diabetes: Functional, immunohistochemical and molecular biological correlations. Am J Physiol 265: F477-F486, 1993
12. Wolf G, Ziladeh FN: The role of angiotensin II in diabetic nephropathy: Emphasis on non-hemodynamic mechanisms. Am J Kidney Dis 29: 153-163, 1997
13. Kagami SK, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of TGF-β expression in rat glomerular mesangial cells. J Clin Invest 93: 2431-2437, 1994
14. Bohrer MP, Deen WM, Robertson CR, Brenner BM: Mechanism of angiotensin II-induced proteinuria in the rat. Am J Physiol 233: F13-F21, 1977
15. Lapinski R, Perico N, Remuzzi A, Sangalli F, Benigni A, Remuzzi G: Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney. J Am Soc Nephrol 7: 653-660, 1996
16. Sadoshima J, Xu Y, Slayter HS, Izumo S: Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977-984, 1993
17. Sudhir K, Wilson E, Chatterjee K, Ives HE: Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells. J Clin Invest 92: 3003-3007, 1993
18. Hirakata M, Kaname S, Chung U, Joki N, Hori Y, Noda M, Takuda Y, Okazaki T, Fujita T, Katoh T, Kurokawa K: Tyrosine kinase dependent expression of TGF-β induced by stretch in mesangial cells. Kidney Int 51: 1028-1036, 1997
19. Iijima K, Yoshikawa N, Connoly DT, Nakamura H: Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int 44: 959-966, 1993
20. Striker GE, Striker LJ: Biology of disease: Glomerular cell culture. Lab Invest 53: 122-131, 1985
21. Beaufils H, Patte R, Aubert P, Camey M, Kuss R, Barbagelatta M, Chomette G: Renal immunopathology in renal cell carcinoma. Virchows Arch A Pathol Anat Histopathol 404: 87-97. 1984
22. Sacks S, Zhou W, Campbell RD, Martin J: C3 and C4 gene expression and IFN-γ-mediated regulation in human glomerular mesangial cells. Clin Exp Immunol 93: 411-417, 1993
23. Barnes AJ, Gilbert J, Taylor D, Monbureau O: A new vacuum-operated stress-providing instrument that applies static or variable duration cycling tension or compression to cells in vitro. J Cell Sci 75: 35-42, 1985
24. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954, 1991
25. Maier JAM, Voulalas PM, Roeder D, Maciag T: Extension of the life-span of human endothelial cells by an interleukin-1α anti-sense oligomer. Science 249: 1570-1574, 1990
26. Gilliland G, Perrin S, Blanchard K, Bunn HF: Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 87: 2725-2729, 1990
27. Cell FS, Zenilman ME, Shuldiner AR: A rapid and versatile method to synthesize internal standards for competitive PCR [Abstract]. Nucleic Acids Res 21: 1047, 1993
28. Kijima K, Matsubara H, Murasawa S, Maruyama S, Mori Y, Ohkubo N, Komuro I, Yazaki Y, Iwasaka T, Inada M: Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes. Circ Res 79: 887-897, 1996
29. Sato K, Yamazaki K, Shizume K, Kanaji Y, Obara T, Ohsumi K, Demura H, Yamaguchi S, Shibuya M: Stimulation by thyroidstimulating hormone and Graves' immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo. J Clin Invest 96: 1295-1302, 1995
30. Chansel D, Czekalski S, Pham P, Ardaillou R: Characterization of angiotensin II receptor subtypes in human glomeruli and mesangial cells. Am J Physiol 262: F432-F441, 1992
31. Dudley DT, Panek RL, Major TC, Lu GH, Bruns RF, Klinkefus BA, Hodges JC, Weishaar RE: Subclasses of angiotensin II binding sites and their functional significance. Mol Pharmacol 38: 370-377, 1990
32. Wong PC, Hart SD, Zaspel AM, Chiu AT, Ardecky RJ, Smith RD, Timmermans PBMWM: Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP753 (AII-1) and PD123177 (AII-2). J Pharmacol Exp Ther 255: 584-592, 1990
33. Wolf G, Haberstroh U, Neilson EG: Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140: 95-107, 1992
34. Naitoh M, Suzuki H, Arakawa K, Matsumoto A, Ichihara A, Matsuda H, Murakami M, Nakamoto H, Saruta T: Role of kinin and renal angiotensin II blockade in the effects of ACE inhibitors in low renin hypertension. Am J Physiol 272: H679-H687, 1997
35. Seikaly GM, Arant BJ, Seney FJ: Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rats. J Clin Invest 86: 1352-1357, 1990
36. Finkenzeller G, Marme D, Weich HA, Hug H: Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Res 52: 4821-4823, 1992
37. Iwai NY, Yamano S, Chaki S, Konishi R, Bardhan S, Tibbetts C, Sasaki K, Sasegawa M, Matsuda Y, Inagami T: The angiotensin II receptor cDNA sequence and regulation of the gene expression. Biochem Biophys Res Commun 177: 299-304, 1991
38. Opperman M, Freedman NJ, Alexander RW, Lefkowitz RJ: Phosphorylation of the type 1A angiotensin II receptor by G-protein-coupled receptor kinases and protein kinase C. J Biol Chem 271: 13266-13272, 1996
39. Anderson PW, Zhang XY, Tina J, Correale JD, Xi XP, Yang D, Graf K, Law RE, Hsueh WA: Insulin and angiotensin II are additive in stimulating TGF-β and matrix mRNAs in mesangial cells. Kidney Int 50: 745-753, 1996
40. Anderson P, Do YS, Hsueh WA: Angiotensin II causes mesangial cell hypertrophy. Hypertension 21: 29-35, 1993
41. Ray PE, Bruggeman LA, Horikosi S, Aguilera G, Kootman PE: Angiotensin II stimulates human mesangial cell proliferation and fibronectin synthesis and binding to AT1 receptor. Kidney Int 45: 177-184, 1994
42. Williams B, Baker AQ, Gallacher B, Lodwick D: Angiotensin II increases vascular permeability factor gene by human vascular smooth muscle cells. Hypertension 25: 913-917, 1995
43. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ: Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 91: 2268-2274, 1993
44. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Mizuno T, Takano H, Hiroi Y, Ueki K, Tobe K, Kadowaki T, Nagai R, Yazaki Y: Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. Circ Res 77: 258-265, 1995
45. Gruden G, Thomas S, Sacks S, Viberti GC: Mechanical stretch induces TGF-β1 gene expression and protein secretion in human mesangial cells [Abstract]. Diab Med 13[Suppl 3]: P96, 1995
46. Riser BL, Cortes P, Heilig C, Grondin J, Ladson-Wofford S, Patterson D, Narins RG: Cyclic stretching force selectively up-regulates transforming growth factor-β isoforms in cultured rat mesangial cells. Am J Pathol 148: 1915-1923, 1996